01 test content and outsourcing rate of independent medical laboratories
The inspection items specified in the catalogue of clinical inspection items of medical institutions belong to the items in the table, which are called general inspection. They are charged uniformly according to national regulations. At present, the general inspection items are in a large-scale pattern, and most of them are contracted by Guangzhou Kingmed Diagnostics Group Co.Ltd(603882) and Dian Diagnostics Group Co.Ltd(300244) . For the downstream of the industrial chain, public primary and secondary hospitals are the main customers of general inspection outsourcing, accounting for more than 80% of the inspection outsourcing market of public primary and secondary hospitals.
The off balance sheet items in the catalogue of clinical examination items of medical institutions are called special examination. The fees for special examination are not unified. Fees are charged according to the prices of different laboratories. Public hospitals outsource to third-party medical laboratories, and the laboratories set prices independently. For the downstream of the industrial chain, public tertiary hospitals are the main customers of general examination outsourcing, accounting for more than 80% of the market of hospital examination outsourcing, Therefore, the special inspection industry currently belongs to the blue ocean and has considerable growth space in the future.
02 current situation of general inspection and special inspection market
In 2020, the market scale of special inspection will be about 13.73 billion (excluding covid-19), accounting for 52.7% of the total ICL market. It is estimated that the compound growth rate of the special inspection market is expected to reach 15.1% from 2020 to 2024. Due to the mature technology and water means, low technical barriers, low willingness of hospital inspection outsourcing, relatively low inspection added value, and the price of about 70 yuan, the market competition is fierce. Therefore, the compound growth rate is lower than that of the special inspection. The national general inspection market will be large in 2020 About RMB 12.331 billion, with a compound growth rate of 10.61% from 2020 to 2024.
The economic added value of special inspection is high. Because there is no unified charge, the outsourcing laboratory sets the price independently, with a high degree of freedom of pricing power, and the average price is about 450 yuan. At the same time, due to the large number of industry segments and the continuous emergence of emerging testing industries, such as colorectal cancer early screening and blood disease examination, which give new vitality to the special testing City, the special testing market is growing rapidly.
Is the Growth Logic of China’s ICL market consistent with that of Japan and the United States?
The health care systems of Japan, the United States and China are inverted, so the penetration can not be compared in the same dimension. In Japan and the United States, small medical institutions and private doctors are the main entrances for patient flow, and such medical institutions naturally rely on ICL. Patients need to make a test first and then make an appointment to see a doctor. Public hospitals in China are the main flow entrance for patients, with complete equipment. Most of them can provide testing equipment, and the possibility of outsourcing general inspection business is low
